Xiaoxia Cui

618 total citations
24 papers, 464 citations indexed

About

Xiaoxia Cui is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xiaoxia Cui has authored 24 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Xiaoxia Cui's work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). Xiaoxia Cui is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). Xiaoxia Cui collaborates with scholars based in China, United States and Australia. Xiaoxia Cui's co-authors include Peng Song, Li Zhang, Hanping Wang, Xiaotong Zhang, Dingding Zhang, Xiaoyan Si, Li Zhang, Steven M. Rowe, Kengyeh K. Chu and Li Tang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaoxia Cui

21 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxia Cui China 10 191 185 137 43 40 24 464
Chaitra Cheluvaraju United States 4 176 0.9× 268 1.4× 66 0.5× 39 0.9× 14 0.3× 7 486
Chithra D. Palani United States 13 317 1.7× 68 0.4× 111 0.8× 68 1.6× 23 0.6× 21 598
Gitte Berkers Netherlands 10 182 1.0× 401 2.2× 125 0.9× 17 0.4× 28 0.7× 17 650
Mei-I Chung United States 4 190 1.0× 316 1.7× 86 0.6× 35 0.8× 26 0.7× 4 544
Diane Foster United Kingdom 6 293 1.5× 212 1.1× 213 1.6× 40 0.9× 30 0.8× 7 597
Iris A. L. Silva Portugal 14 202 1.1× 375 2.0× 39 0.3× 42 1.0× 32 0.8× 38 562
Marsha-Kay Hutchinson United States 5 152 0.8× 88 0.5× 217 1.6× 117 2.7× 85 2.1× 5 492
Aparna Ramasubramanian United States 16 104 0.5× 55 0.3× 98 0.7× 42 1.0× 33 0.8× 75 781
Satoshi Ikeo Japan 8 363 1.9× 266 1.4× 106 0.8× 19 0.4× 21 0.5× 22 679
Ken Nakatani Japan 13 209 1.1× 79 0.4× 152 1.1× 31 0.7× 10 0.3× 40 469

Countries citing papers authored by Xiaoxia Cui

Since Specialization
Citations

This map shows the geographic impact of Xiaoxia Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxia Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxia Cui more than expected).

Fields of papers citing papers by Xiaoxia Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxia Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxia Cui. The network helps show where Xiaoxia Cui may publish in the future.

Co-authorship network of co-authors of Xiaoxia Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxia Cui. A scholar is included among the top collaborators of Xiaoxia Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxia Cui. Xiaoxia Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Li, Rui Meng, Jing Zhang, et al.. (2025). Safety and Efficacy of the First Subcutaneous ICI, Envafolimab, in the Treatment of Advanced Lung Cancer Patients: A Real‐World Study. Thoracic Cancer. 16(12). e70101–e70101.
2.
Cui, Xiaoxia, X. B. Ji, Xuan Zhang, et al.. (2024). Cobalt coordinated olefin-linked covalent organic frameworks toward highly efficient photocatalytic hydrogen production. Applied Surface Science. 684. 161988–161988. 4 indexed citations
3.
Cui, Xiaoxia, et al.. (2023). The level of serum retinol-binding protein is associated with diabetic mild cognitive impairment. Brain Research. 1822. 148670–148670.
4.
Yan, Teng, et al.. (2023). Enhancing photocatalytic C-O/N coupling reaction over covalent organic frameworks by pull-push electron group regulation. Applied Catalysis A General. 661. 119245–119245. 6 indexed citations
5.
6.
Wu, Xiang, et al.. (2021). Expression of miR-92a in colon cancer tissues and its correlation with clinicopathologic features and prognosis.. American Journal of Translational Research. 13(8). 9627–9632. 5 indexed citations
7.
Song, Peng, Dingding Zhang, Xiaoxia Cui, & Li Zhang. (2020). Meta‐analysis of immune‐related adverse events of immune checkpoint inhibitor therapy in cancer patients. Thoracic Cancer. 11(9). 2406–2430. 50 indexed citations
8.
Song, Peng, Hanping Wang, Xiaoxia Cui, et al.. (2020). Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non‐small cell lung cancer patients. Thoracic Cancer. 11(6). 1647–1654. 19 indexed citations
9.
Song, Peng, Hanping Wang, Xiaoxia Cui, et al.. (2020). Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients. Thoracic Cancer. 11(6). 1621–1632. 66 indexed citations
10.
Song, Peng, Dongliang Yang, Xiaoxia Cui, et al.. (2020). <p>NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score</p>. Cancer Management and Research. Volume 12. 5975–5985. 8 indexed citations
11.
Vanslambrouck, Jessica M., Sean B. Wilson, Ker Sin Tan, et al.. (2019). A Toolbox to Characterize Human Induced Pluripotent Stem Cell–Derived Kidney Cell Types and Organoids. Journal of the American Society of Nephrology. 30(10). 1811–1823. 41 indexed citations
12.
13.
Hu, Xingsheng, Xixi Zheng, Hongnan Mo, et al.. (2018). P1.01-37 BPI-9016M, a Novel c-Met Inhibitor, in Pretreated Advanced Solid Tumor: Results from a First-In-Human, Phase 1, Dose-Escalation Study. Journal of Thoracic Oncology. 13(10). S474–S474. 1 indexed citations
14.
Liu, Jinqi, Ren Liu, Peter C. Gray, et al.. (2017). Development of a luciferase reporter Jurkat cell line under the control of endogenous interleukin-2 promoter. Journal of Immunological Methods. 451. 48–53. 2 indexed citations
15.
Zhang, Guoqing, Fang Li, Shengjie Sun, et al.. (2015). Adoptive Immunotherapy for Small Cell Lung Cancer by Expanded Activated Autologous Lymphocytes: a Retrospective Clinical Analysis. Asian Pacific Journal of Cancer Prevention. 16(4). 1487–1494. 6 indexed citations
16.
Liu, Qi, Cheng‐Hu Hu, Cuihong Zhou, et al.. (2015). DKK1 rescues osteogenic differentiation of mesenchymal stem cells isolated from periodontal ligaments of patients with diabetes mellitus induced periodontitis. Scientific Reports. 5(1). 13142–13142. 48 indexed citations
17.
18.
Tuggle, Katherine L., Susan E. Birket, Xiaoxia Cui, et al.. (2014). Characterization of Defects in Ion Transport and Tissue Development in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Knockout Rats. PLoS ONE. 9(3). e91253–e91253. 122 indexed citations
19.
McCoy, Aaron, Cynthia Besch‐Williford, Craig L. Franklin, Edward J. Weinstein, & Xiaoxia Cui. (2012). Creation and preliminary characterization of a Tp53 knockout rat. Disease Models & Mechanisms. 6(1). 269–78. 13 indexed citations
20.
Vaira, Sergio, Chang Yang, Aaron McCoy, et al.. (2012). Creation and Preliminary Characterization of a Leptin Knockout Rat. Endocrinology. 153(11). 5622–5628. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chaitra Cheluvaraju Breakdown of academic impact, for papers by Chithra D. Palani Breakdown of academic impact, for papers by Gitte Berkers Breakdown of academic impact, for papers by Mei-I Chung Breakdown of academic impact, for papers by Diane Foster Breakdown of academic impact, for papers by Iris A. L. Silva Breakdown of academic impact, for papers by Marsha-Kay Hutchinson Breakdown of academic impact, for papers by Aparna Ramasubramanian Breakdown of academic impact, for papers by Satoshi Ikeo Breakdown of academic impact, for papers by Ken Nakatani
Rankless by CCL
2026